PRELID3B

Across TCGA patient cohorts, PRELID3B mutation is significantly associated with the immune_cell of many other genes, with 4 significant associations in total. UCEC shows the largest number of these associations.

The most reproducible PRELID3B-associated genes across cancer lineages are Mesangial cells, Endothelial cells, and lymphatic Endothelial cells. Each is linked with PRELID3B in more than 1 cancer types. Because this analysis shows association rather than direction, both PRELID3B-to-partner and partner-to-PRELID3B results are reported.

Each partner links to its own Q-omics profile. The box plot shows the strongest example, Mesangial cells grouped by PRELID3B-low versus PRELID3B-high in UCEC.

mutation associated genes by consensus

Ranked by combined sampling and lineage consensus. X-score (PRELID3B→partner) and Y-score (partner→PRELID3B) are standardized regression coefficients; both directions are reported because the association is undirected. p-values are from the association test.

Lineage	Partner gene	X-score	Y-score	p(X)	p(Y)	Sampling consensus	Lineage consensus
UCEC	Mesangial cells →	-0.068	-3.311	<.001	.010	3	1
UCEC	Endothelial cells →	-0.056	-3.279	.005	.011	1	1
UCEC	lymphatic Endothelial cells →	-0.032	-3.268	.011	.011	1	1
UCEC	mv Endothelial cells →	-0.033	-3.311	.008	.010	1	1

Each partner links to its Q-omics profile. Showing the 4 strongest of 4 associations by consensus.

Mesangial cells by PRELID3B expression — UCEC

Explore this box plot interactively →